Literature DB >> 27094476

Prevalence of KISS1 Receptor mutations in a series of 603 patients with normosmic congenital hypogonadotrophic hypogonadism and characterization of novel mutations: a single-centre study.

Bruno Francou1, Charlotte Paul2, Larbi Amazit3, Alejandra Cartes4, Claire Bouvattier5, Frédérique Albarel6, Dominique Maiter7, Philippe Chanson8, Séverine Trabado1, Sylvie Brailly-Tabard1, Thierry Brue6, Anne Guiochon-Mantel1, Jacques Young9, Jérôme Bouligand1.   

Abstract

STUDY QUESTION: What is the exact prevalence of Kisspeptin Receptor (KISS1R) mutations in the population of patients with normosmic congenital hypogonadotrophic hypogonadism (nCHH) by comparison with other genes, involved in gonadotrophin-releasing hormone (GnRH) release or action? SUMMARY ANSWER: KISS1R mutants are responsible for the nCHH phenotype in only a small minority of cases and were less prevalent than GnRH Receptor (GNRHR) mutations. WHAT IS KNOWN ALREADY: The respective prevalence of each of the genetic causes of nCHH is unclear. Large series of patients are very rare and suffer from heterogeneity of the population of CHH studied. STUDY DESIGN, SIZE, DURATION: Patients with nCHH were consecutively enrolled in a single French referral centre and were gradually tested for KISS1R between January 2006 and April 2015. PARTICIPANTS/MATERIALS, SETTING,
METHODS: A total of 603 patients with nCHH (399 men and 204 women) were diagnosed at the Bicêtre Hospital and underwent KISS1R analysis. The GNRHR, tachykinin receptor 3 (TACR3), gonadotrophin-releasing hormone 1 (GNRH1), tachykinin 3 (TAC3) and KISS1 genes were also sequenced. Functional characterization of KISS1R mutations included a study of signal transduction using a reporter gene (serum response element-luciferase (SRE-Luc) involved in the mitogen-activated protein (MAP) kinase pathway. MAIN RESULTS AND THE ROLE OF CHANCE: We detected 15 KISS1R variants (10 novel), in 12 of the 603 patients (2.0%, 95% CI [0.9-3.1]. KISS1R mutations were less prevalent than GNRHR (4.7%) and TACR3 (2.6%) mutations but more prevalent than GNRH1 (1.5%), TAC3 (1.0%) and KISS1 (0%) mutations. KISS1R mutants were present in the biallelic state in 8 of the 12 patients concerned. Among 5 men with biallelic KISS1R mutations, 4 had either micropenis or cryptorchidism. In vitro analysis of the 5 new variants present in the biallelic state (C95W, Y103*, C115W, P176R and A287E) showed a loss of function. LIMITATIONS, REASONS FOR CAUTION: The prevalence of TACR3, GNRH1, TAC3 and KISS1 mutations was calculated from a smaller number of nCHH patients than KISS1R and GNRHR. This should prompt caution concerning the reported prevalence of mutations in these four genes. WIDER IMPLICATIONS OF THE
FINDINGS: We show that KISS1R mutants are responsible for the nCHH phenotype in only a small minority of cases. Together, the genes analysed here were mutated in fewer than 15% of patients, suggesting a role of other genes in nCHH. The presence of cryptorchidism and/or micropenis in the majority of men with biallelic KISS1R mutations strongly suggests that this gene is essential for prenatal GnRH secretion. STUDY FUNDING, COMPETING INTERESTS: This work was supported in part by grants from Paris-Sud University (Bonus Qualité Recherche, and Attractivité grants) to J.B., French Ministry of Health, Hospital Clinical Research Program on Rare Diseases. Assistance Publique Hôpitaux de Paris, Programme Hospitalier de Recherche Clinique (PHRC # P081212 HYPOPROTEO) to J.Y. C.P. was supported by student fellowships 'Année Recherche' from Agence Régionale de Santé Provence Alpes Côtes d'Azur. The authors have nothing to disclose.
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  GNRHR/GNRH1; GPR54; Kallmann; TAC3/TACR3; delayed puberty; neurokinin B

Mesh:

Substances:

Year:  2016        PMID: 27094476     DOI: 10.1093/humrep/dew073

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  12 in total

1.  Whole Exome Sequencing Points towards a Multi-Gene Synergistic Action in the Pathogenesis of Congenital Combined Pituitary Hormone Deficiency.

Authors:  Amalia Sertedaki; Elizabeth Barbara Tatsi; Ioannis Anargyros Vasilakis; Irene Fylaktou; Eirini Nikaina; Nicoletta Iacovidou; Tania Siahanidou; Christina Kanaka-Gantenbein
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 2.  Review of human genetic and clinical studies directly relevant to GnRH signalling.

Authors:  Stephanie B Seminara; A Kemal Topaloglu
Journal:  J Neuroendocrinol       Date:  2021-12-31       Impact factor: 3.870

3.  Kisspeptin deficiency leads to abnormal adrenal glands and excess steroid hormone secretion.

Authors:  Annabel Berthon; Nikolaos Settas; Angela Delaney; Andreas Giannakou; Andrew Demidowich; Fabio R Faucz; Stephanie B Seminara; Margaret E Chen; Constantine A Stratakis
Journal:  Hum Mol Genet       Date:  2020-12-18       Impact factor: 6.150

Review 4.  Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease.

Authors:  Richard Quinton; Marco Bonomi; Biagio Cangiano; Du Soon Swee
Journal:  Hum Genet       Date:  2020-03-21       Impact factor: 4.132

5.  Conformational Change in the Ligand-Binding Pocket via a KISS1R Mutation (P147L) Leads to Isolated Gonadotropin-Releasing Hormone Deficiency.

Authors:  Koichiro Shimizu; Tadato Yonekawa; Morikatsu Yoshida; Mikiya Miyazato; Ayako Miura; Hideyuki Sakoda; Hideki Yamaguchi; Masamitsu Nakazato
Journal:  J Endocr Soc       Date:  2017-09-05

6.  Three Siblings with Idiopathic Hypogonadotropic Hypogonadism in a Nonconsanguineous Family: A Novel KISS1R/GPR54 Loss-of-Function Mutation

Authors:  Özlem Nalbantoğlu; Gülçin Arslan; Özge Köprülü; Filiz Hazan; Semra Gürsoy; Behzat Özkan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-03-25

Review 7.  Genetic Evaluation of Patients With Delayed Puberty and Congenital Hypogonadotropic Hypogonadism: Is it Worthy of Consideration?

Authors:  Adalgisa Festa; Giuseppina Rosaria Umano; Emanuele Miraglia Del Giudice; Anna Grandone
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-19       Impact factor: 5.555

8.  A case report of congenital idiopathic hypogonadotropic hypogonadism caused by novel mutation of GNRHR gene.

Authors:  Liping Wang; Weisheng Lin; Xiaohong Li; Lijuan Zhang; Kai Wang; Xiaoli Cui; Shanmei Tang; Guangguang Fang; Yan Tan; Xuelai Wang; Chuan Chen; Chuanchun Yang; Huiru Tang
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

9.  Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures.

Authors:  Daniele Cassatella; Sasha R Howard; James S Acierno; Cheng Xu; Georgios E Papadakis; Federico A Santoni; Andrew A Dwyer; Sara Santini; Gerasimos P Sykiotis; Caroline Chambion; Jenny Meylan; Laura Marino; Lucie Favre; Jiankang Li; Xuanzhu Liu; Jianguo Zhang; Pierre-Marc Bouloux; Christian De Geyter; Anne De Paepe; Waljit S Dhillo; Jean-Marc Ferrara; Michael Hauschild; Mariarosaria Lang-Muritano; Johannes R Lemke; Christa Flück; Attila Nemeth; Franziska Phan-Hug; Duarte Pignatelli; Vera Popovic; Sandra Pekic; Richard Quinton; Gabor Szinnai; Dagmar l'Allemand; Daniel Konrad; Saba Sharif; Özlem Turhan Iyidir; Brian J Stevenson; Huanming Yang; Leo Dunkel; Nelly Pitteloud
Journal:  Eur J Endocrinol       Date:  2018-02-01       Impact factor: 6.664

10.  An Isolated Hypogonadotropic Hypogonadism due to a L102P Inactivating Mutation of KISS1R/GPR54 in a Large Family.

Authors:  Ahmad J Alzahrani; Azzam Ahmad; Tariq Alhazmi; Lujin Ahmad
Journal:  Case Rep Pediatr       Date:  2019-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.